Clinical Study

A Phase 1 Study Of Stereotactic Body Radiotherapy (Sbrt) For The Treatment Of Multiple Metastases

Posted Date: Mar 31, 2017

  • Investigator: Kevin Redmond
  • Co-Investigator: Andrea Collins
  • Specialties: Breast Cancer, Hematology/Oncology, Prostate Cancer, Oncology, Cancer, Lung Cancer, Radiation Oncology
  • Type of Study: Drug

This research is being done to study the safety of giving high doses of radiation to cancer that has spread to other parts of the body. This type of radiation is called stereotactic body radiotherapy [SBRT]). SBRT delivers high doses of radiation to an


To Be Eligible For This Study, Patients Must Have Breast, Lung Or Prostate Cancer That Has Spread To Other Parts Of The Body.


Phase I, Cancer, Nrg-Br001, Radiation, Solid Tumor

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.